Rosacea Review - Newsletter of the National Rosacea SocietyRosacea Review - Newsletter of the National Rosacea Society

Survey Finds Insurance Coverage, Cost Influence Treatment Decisions

A recent survey by the NRS found that the majority of rosacea patients have insurance coverage for common treat- ments they need, but revealed that out-of- pocket cost is still a factor for most indi- viduals when they make decisions about purchasing prescribed therapies.

Common rosacea medical therapies are fully covered by insurance for 19% of the 325 survey respondents and partially covered for 34%. Another 23% said their insurance only minimally covered their treatment, while 21% reported their insurance does not cover rosacea therapy at all. Around 3% of survey respondents had no health insurance.

However, 70% of those surveyed said the cost of medical therapies for rosacea has influenced which treatments they’ve tried or currently use, and 63% of respon- dents reported having stopped or avoided treatment altogether because of cost of medications. This is especially true as out-of-pocket expenses increase. About a quarter of respondents said they paid more than $100 a month out of pocket, and this group was nearly 20% more likely to be influenced by the cost of their treatment choices compared with those whose treatment was under $100 a month, and about 20% more likely to have stopped or avoided treatment.

Over-the-counter availability was a major draw: more than 76% of respon- dents said they would be more likely to use a medical therapy if it was available for over-the-counter purchase.